Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 25;17(6):e86717.
doi: 10.7759/cureus.86717. eCollection 2025 Jun.

Navigating Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging (O-RADS MRI): A Review of Its Evolution, Current Advances, and Persistent Challenges in Ovarian Imaging

Affiliations
Review

Navigating Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging (O-RADS MRI): A Review of Its Evolution, Current Advances, and Persistent Challenges in Ovarian Imaging

Rahul Dev et al. Cureus. .

Abstract

The Ovarian-Adnexal Reporting and Data System magnetic resonance imaging (O-RADS MRI) is a standardized risk stratification system designed to enhance uniform interpretation and reporting of adnexal masses on MRI. A PubMed search was conducted using the keyword "O-RADS MRI," yielding 61 articles in the search results. After excluding eight articles, 53 articles were selected. Additionally, five articles were identified through a citation search. A total of 58 articles were included in this literature review. Ultrasonography (USG) is the primary imaging modality used for evaluating adnexal lesions, with MRI reserved for cases that require further evaluation. Based on both USG and MRI imaging, various scores are assigned to a particular lesion. Contrast imaging, utilizing both ultrasound USG and MRI, is employed for the better characterization of lesions in terms of internal morphology, with a primary focus on solid components. Additionally, internal septation, wall characteristics, and other soft tissue components, including fat, fibrous tissue, and blood products, are also evaluated. Advanced MRI techniques, such as diffusion-weighted imaging and dynamic contrast-enhanced sequences, also help refine the final O-RADS score of a lesion. Contrast-Enhanced Computed Tomography (CECT) plays a predominant role in evaluating metastatic disease and has been established in five cases. This review article provides a comprehensive overview of O-RADS MRI, addressing its development, key imaging features, and practical application in a clinical setup. We discuss the diagnostic performance of O-RADS MRI in differentiating benign from malignant adnexal lesions, exploring its strengths in reducing inter-observer variability and guiding patient management. We also highlighted various comparative studies and trials that have shaped the evolution of the O-RADS MRI system over time. Furthermore, this article highlights the challenges associated with implementing O-RADS MRI, including potential pitfalls in interpretation, corroborations, and discordance with other imaging modalities, particularly USG, as well as the need for further validation studies.

Keywords: adnexal mass lesion; cect; dwi-adc; mri; o-rads mri; time-signal intensity curve; usg.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. PRISMA flowchart summarizes the study selection process.
PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses

Similar articles

References

    1. Comparative study of the efficacy of the Ovarian-Adnexa Reporting and Data System ultrasound combined with contrast-enhanced ultrasound and the ADNEX MR scoring system in the diagnosis of adnexal masses. Wang T, Cui W, Nie F, et al. Ultrasound Med Biol. 2023;49:2072–2080. - PubMed
    1. Ovarian Adnexal Reporting and Data System (O-RADS) for classifying adnexal masses: a systematic review and meta-analysis. Vara J, Manzour N, Chacón E, et al. Cancers (Basel) 2022;14 - PMC - PubMed
    1. Contemporary guidelines for adnexal mass imaging: a 2020 update. Stein EB, Roseland ME, Shampain KL, Wasnik AP, Maturen KE. Abdom Radiol (NY) 2021;46:2127–2139. - PubMed
    1. Ovarian-Adnexal Reporting and Data System magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A, et al. JAMA Netw Open. 2020;3:0. - PMC - PubMed
    1. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses. Wu M, Tang Q, Cai S, et al. Eur J Radiol. 2023;159:110670. - PubMed

LinkOut - more resources